Available until 5/1/2021
Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Acute Allergic Reactions to mRNA COVID-19 Vaccines
TAKE-HOME MESSAGE
- This study out of Mass General Brigham in Boston assessed allergic reactions to the Pfizer and Moderna COVID vaccines. Researchers found allergic reactions developed in about 2% of individuals, with more reactions from the Moderna vaccine.
- Anaphylaxis was very rare (2.47 per 10,000 vaccinations), and 31% of the individuals who experienced anaphylaxis with COVID vaccination had a history of anaphylaxis with vaccination.
abstract
This abstract is available on the publisher's site.
Access this abstract nowAnaphylaxis to the mRNA COVID-19 vaccines is currently estimated to occur in 2.5 to 11.1 cases per million doses, largely in individuals with a history of allergy. Allergic concerns contribute to vaccine hesitancy; we investigated acute allergic reaction incidence after more than 60 000 mRNA COVID-19 vaccine administrations.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Acute Allergic Reactions to mRNA COVID-19 Vaccines
JAMA 2021 Mar 08;[EPub Ahead of Print], KG Blumenthal, LB Robinson, CA Camargo, ES Shenoy, A Banerji, AB Landman, P WicknerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.